Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Acura Pharmaceuticals (ACUR) has shared an update.
Peter A. Clemens, Sr. Vice President and CFO of Acura Pharmaceuticals, is set to retire on September 30, 2024, with a planned transition period until then. Robert A. Seiser, with the company since 1998 and currently its VP Treasurer and Corporate Controller, will succeed Clemens as the new CFO starting August 1, 2024. This executive shift marks a significant change in Acura’s financial leadership.
See more insights into ACUR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue